OpenContracts

Amgen Ltd

Awards
24
Value outside frameworks
-
Framework places
6
Shared awards
17

Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together.

Awards

ProcurementBuyerValueDate
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Lot 1 framework NHS England £665,389,588 6 Jul 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 2 framework NHS England £18,903,212 6 Jul 2026
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Lot 1 framework NHS England £665,389,588 15 Jun 2026
Transitional Drugs 7 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £16,804,001 4 Jun 2026
Ustekinumab shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £6,532,463 4 Jun 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 1 framework NHS England £813,863,584 1 Jun 2026
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 Lot 2 framework NHS England £18,903,212 1 Jun 2026
Transitional Drugs 6 shared NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) £1,637,726 29 Jan 2026
NHS National Framework for Denosumab Injection commencing 1st January 2026 framework NHS England £15,059,000 30 Sep 2025
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche NHS England - 11 Feb 2021
NHS Framework for the Midlands and East, Branded Medicines - Tranche B shared NHS England £228,156,862 25 Jan 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 17 Jun 2020
NHS Framework Agreement - North of England - Tranche B shared NHS England £205,535,556 13 Feb 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS South of England Branded Medicines - Tranche A - Contracts Finder Award Notice shared NHS England £188,004,961 1 Aug 2019
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity shared NHS England £251,930,337 5 Jul 2019
NHS Framework agreement for Branded Medicines - North of England - Tranche A shared NHS England £204,551,038 18 Feb 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS England - Midlands and East Branded Medicines - Tranche B shared NHS England £295,035,882 17 Jan 2019
NHS National Framework Agreement for the Supply of Adalimumab shared NHS England £159,371,013 1 Dec 2018
NHS England Framework Agreement - London - Tranche A shared NHS England £211,435,404 15 Aug 2018
NHS Framework Agreement for Trastuzumab Injection shared NHS England £226,961,206 16 Jul 2018

Top buyers

By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.